ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

OSL Oncosil Medical Ltd

0.007
0.00 (0.00%)
27 Nov 2024 - Closed
Delayed by 20 minutes
Share Name Share Symbol Market Type
Oncosil Medical Ltd ASX:OSL Australian Stock Exchange Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.007 0.008 0.007 0.00 20:00:43

Rule 8 - Osborne & Little PLC

21/05/2003 1:36pm

UK Regulatory


RNS Number:3747L
Sharp (James) & Co
21 May 2003



                                  Date of Disclosure    21ST MAY 2003

                    DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) and 8.3 
                       OF THE CITY CODE ON TAKEOVERS AND MERGERS

Date of dealing    21ST MAY 2003

Dealing in     OSBORNE & LITTLE PLC         (name of company)

1)  Class of securities (eg ordinary shares)    ORDINARY SHARES GBP 0.05

2)  Amount bought                Amount sold             Price per unit
       1,300                                                  190P


3)  Resultant total of the same class owned or controlled 
    (and percentage of class)      200,000 SHARES            (3.32%)


4) Party making disclosure      JAMES SHARP & CO


5)  EITHER (a) Name of purchaser/vendor (Note 1)  LYNNIG LIMITED  
    OR     (b) if dealing for discretionary client(s), name of fund 
               management organisation

6)  Reason for disclosure (Note 2)                                     
    (a) associate of (i) offeror (Note 3)                           NO
                    (ii) offeree company                            NO

Specify which category or categories of associate (1-8 overleaf) 

If category (8), explain

     (b)  Rule 8.3 (ie disclosure because of ownership or control of 1% 
          or more of the class of relevant securities dealt in)     YES

Signed, for and on behalf of the party named in (4) above  N/A  

(Also print name of signatory)     MICHAEL TULIP

Telephone and extension number     0161 764 4043


Note 1.  Specify owner, not nominee or vehicle company.  If relevant, also 
         identify controller of owner, eg where an owner normally acts on 
         instructions of a controller

Note 2.  Disclosure might be made for more than one reason; if so, state all 
         reasons.

Note 3.  Specify which offeror if there is more than one.

Note 4.  When an arrangement exists with any offeror, with the offeree company 
         or which an associate of any offeror or of the offeree company 
         in relation to relevant securities, details of such arrangement must 
         be disclosed, as required by Note 6 on Rule 8

Note 5.  It may be necessary, particularly when disclosing derivative 
         transactions, to append a sheet to this disclosure form so that
         relevant information can be given.

Note 6.  In the case of an average price bargain, each underlying trade 
         should be disclosed.

For full details of disclosure requirements, see Rule 8 of the Code.  If in 
doubt, contact the Panel on Takeovers and Mergers, Tel No: 020 7382 9026



                                  Date of Disclosure  21ST MAY 2003

                    DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) and 8.3 
                       OF THE CITY CODE ON TAKEOVERS AND MERGERS

Date of dealing     20TH MAY 2003

Dealing in      OSBORNE & LITTLE PLC          (name of company)

1)  Class of securities (eg ordinary shares)  ORDINARY SHARES GBP 0.05

2)  Amount bought                Amount sold             Price per unit
      15,000                                                  190P


3)  Resultant total of the same class owned or controlled 
    (and percentage of class)      198,700 SHARES           (3.29%)


4) Party making disclosure     JAMES SHARP & CO


5)  EITHER (a) Name of purchaser/vendor (Note 1)  LYNNIG LIMITED    
    OR     (b) if dealing for discretionary client(s), name of fund 
               management organisation

6)  Reason for disclosure (Note 2)                                     
    (a) associate of (i) offeror (Note 3)                           NO
                    (ii) offeree company                            NO

Specify which category or categories of associate (1-8 overleaf) 

If category (8), explain

     (b)  Rule 8.3 (ie disclosure because of ownership or control of 1% 
          or more of the class of relevant securities dealt in)      YES

Signed, for and on behalf of the party named in (4) above  N/A  

(Also print name of signatory)   MICHAEL TULIP

Telephone and extension number   0161 764 4043


Note 1.  Specify owner, not nominee or vehicle company.  If relevant, also 
         identify controller of owner, eg where an owner normally acts on 
         instructions of a controller

Note 2.  Disclosure might be made for more than one reason; if so, state all 
         reasons.

Note 3.  Specify which offeror if there is more than one.

Note 4.  When an arrangement exists with any offeror, with the offeree company 
         or which an associate of any offeror or of the offeree company 
         in relation to relevant securities, details of such arrangement must 
         be disclosed, as required by Note 6 on Rule 8

Note 5.  It may be necessary, particularly when disclosing derivative 
         transactions, to append a sheet to this disclosure form so that
         relevant information can be given.

Note 6.  In the case of an average price bargain, each underlying trade 
         should be disclosed.

For full details of disclosure requirements, see Rule 8 of the Code.  If in 
doubt, contact the Panel on Takeovers and Mergers, Tel No: 020 7382 9026



                      This information is provided by RNS
            The company news service from the London Stock Exchange

END

DCCFGGZKMMFGFZM

1 Year Oncosil Medical Chart

1 Year Oncosil Medical Chart

1 Month Oncosil Medical Chart

1 Month Oncosil Medical Chart

Your Recent History

Delayed Upgrade Clock